復星醫藥(02196.HK):控股子公司擬8.09億元受讓廣州新市醫院70%股權
格隆匯11月9日丨復星醫藥(02196.HK)公佈,2021年11月9日,公司控股子公司復星健康與廣州新市醫院、林俊杰及其配偶餘翠林共同簽訂《股權轉讓協議》,復星健康擬現金出資人民幣80,920萬元受讓林俊杰持有的廣州新市醫院70%的股權。
據悉,廣州新市醫院始建於2003年,於2017年9月註冊成為一家營利性三級綜合醫院,註冊地為廣東省廣州市,法定代表人為林浩賢。廣州新市醫院是一所集醫療、教學、科研、預防保健為一體的三級綜合醫院,核定牀位數800張,目前擁有產科、婦科、微創外科、骨科、中西醫結合康復科等30多個科室和超過900名的專業醫護、技術人員及運營管理團隊。廣州新市醫院亦是廣東省普通高等醫學院校教學醫院。
截至公吿日,集團已在華南地區擁有並運營佛山禪醫、深圳恆生醫院等多家在大灣區具有品牌影響力、醫療及學科優勢的營利性綜合醫院,並已基本形成了大灣區城市醫療服務產業的網絡化佈局。廣州新市醫院地處廣州市白雲區核心發展區域,是一家在區域內具備一定市場競爭力的三級綜合醫院,並已形成了一定的診療特色和經營口碑等。此次交易旨在進一步完善集團在華南地區的醫療服務佈局、提升區域協同,從而增強在該區域的市場份額和競爭能力。此次交易完成後,復星健康將持有廣州新市醫院70%的股權,廣州新市醫院將納入集團合併報表範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.